Exporter

You can select particular sections to be included in the output file.
EN
FR

Liste modèle des médicaments essentiels

effacer Trouvé 18 recommandations pour 12 médicaments et 13 équivalents thérapeutiques
Les médicaments retirés et les demandes rejetées ne sont pas indiqués. Les afficher.
18.5. Medicines for diabetes
  1. Canagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    Indications
    Therapeutic equivalent to empagliflozin pour Type 2 diabetes mellitus
  2. Dapagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    Indications
    Therapeutic equivalent to empagliflozin pour Type 2 diabetes mellitus
  3. Dulaglutide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus
  4. Empagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 10 mg; 25 mg
    Indications
    Type 2 diabetes mellitus
  5. Gliclazide Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release
    Indications
    Type 2 diabetes mellitus
  6. Insulin (analogue, long-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution; 100 IU per mL in 10 mL vial solution
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  7. Insulin (analogue, rapid-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per 1 mL in 10 mL vial; 100 IU per 1 mL in 3 mL cartridge; 100 IU per 1 mL in 3 mL pre-filled pen
    Indications
    Type 1 diabetes mellitus Type 2 diabetes mellitus
  8. Insulin (human, intermediate-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  9. Insulin (human, short-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution; 100 IU per mL in 10 mL vial solution; 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  10. Insulin aspart Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 110 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  11. Insulin degludec Informations générales
    Section
    Insulins
    Indications
    Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  12. Insulin detemir Informations générales
    Section
    Insulins
    Indications
    Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  13. Insulin glargine Informations générales
    Section
    Insulins
    Indications
    Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  14. Insulin glulisine Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  15. Insulin lispro Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  16. Liraglutide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus
  17. Metformin Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 500 mg (hydrochloride)
    Indications
    Type 2 diabetes mellitus
  18. Semaglutide Informations générales
    Section
    Hypoglycaemic agents
    • Parenteral > General injections > SC: 0.68 mg per mL; 1.34 mg per mL; 2.68 mg per mL
    Indications
    Type 2 diabetes mellitus
  19. Tirzepatide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus